Holen Sie sich die Stockscreener-App
37.55
0.33%
-0.0469
Schlusskurs vom Vortag:
$37.50
Offen:
$37.45
24-Stunden-Volumen:
19,367
Relative Volume:
0.03
Marktkapitalisierung:
$1.72B
Einnahmen:
$604.93M
Nettoeinkommen (Verlust:
$-31.91M
KGV:
-15.52
EPS:
-2.42
Netto-Cashflow:
$45.67M
1W Leistung:
+11.93%
1M Leistung:
+4.98%
6M Leistung:
+12.00%
1J Leistung:
-27.86%
1-Tages-Spanne:
$37.24
$37.90
1-Wochen-Bereich:
$33.95
$37.93
52-Wochen-Spanne:
$23.91
$55.63
Azenta Inc Stock (AZTA) Company Profile
Firmenname
Azenta Inc
Sektor
Telefon
(978) 262-2400
Adresse
200 SUMMIT DRIVE, BURLINGTON
Vergleichen Sie AZTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
37.48 | 1.72B | 604.93M | -31.91M | 45.67M | -2.42 |
|
ISRG
Intuitive Surgical Inc
|
585.07 | 207.41B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
202.15 | 58.46B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.19 | 39.60B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
250.85 | 36.63B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
42.00 | 32.47B | 27.43B | 1.27B | 1.01B | 1.5829 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-12-19 | Bestätigt | Needham | Buy |
| 2025-10-30 | Hochstufung | Jefferies | Hold → Buy |
| 2025-08-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-07-22 | Fortgesetzt | Stephens | Equal-Weight |
| 2024-12-18 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2024-04-04 | Eingeleitet | Jefferies | Hold |
| 2024-02-01 | Bestätigt | B. Riley Securities | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-02-09 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-03-31 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-03-21 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Azenta Inc Aktie (AZTA) Neueste Nachrichten
Why Azenta (AZTA) Got an Analyst Upgrade After Mixed Results and What It Implies for Automation - Sahm
Why Azenta Inc. stock is seen as undervalued2025 Big Picture & Community Verified Trade Alerts - ulpravda.ru
Azenta (AZTA) Analyst Rating Maintained, Price Target Raised to $39 by TD Cowen | AZTA Stock News - GuruFocus
Buyback Watch: How Azenta Inc. stock performs in rising dollar environmentTrade Analysis Summary & Low Drawdown Investment Strategies - ulpravda.ru
Market Outlook: Will Azenta Inc. stock deliver consistent dividendsJuly 2025 Chart Watch & Expert Approved Trade Ideas - ulpravda.ru
Why Are Azenta (AZTA) Shares Soaring Today - Finviz
Azenta Enters Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L. - citybiz
Allspring Global Investments Holdings LLC Cuts Stock Holdings in Azenta, Inc. $AZTA - MarketBeat
Azenta (NASDAQ:AZTA) Rating Increased to Buy at Wall Street Zen - MarketBeat
Bear of the Day: Azenta (AZTA) - The Globe and Mail
Vale and Azenta have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
Azenta divests B Medical Systems to streamline portfolio - The Globe and Mail
Azenta to sell B Medical Systems business for $63 million By Investing.com - Investing.com Nigeria
Azenta Signs Sale And Purchase Agreement With Thelema - TradingView — Track All Markets
Azenta to sell B Medical Systems business for $63 million - Investing.com
Azenta (AZTA) to Divest B Medical Systems for $63 Million - GuruFocus
Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L. - PR Newswire
Azenta (AZTA): Buy, Sell, or Hold Post Q3 Earnings? - Barchart.com
How Azenta Inc. (BA3) stock stacks up against competitorsMarket Volatility Update & Big Returns, Small Investment - bollywoodhelpline.com
What analyst consensus implies for Azenta Inc. (BA3) stock2025 Price Momentum & Free Low Drawdown Momentum Trade Ideas - Улправда
Is Azenta’s Buyback and M&A Push Recalibrating the Investment Case For Azenta (AZTA)? - simplywall.st
Pharma News: Is Azenta Inc. stock a top pick in earnings seasonMarket Trend Report & Weekly High Potential Stock Alerts - moha.gov.vn
Needham Sticks to Their Buy Rating for Azenta (AZTA) - The Globe and Mail
Stock Market Recap: How Azenta Inc. stock performs after earningsJuly 2025 Technicals & Real-Time Buy Zone Alerts - Улправда
Azenta, Inc. ($AZTA) CEO 2025 Pay Revealed - Quiver Quantitative
How Azenta Inc. stock compares to industry benchmarksMarket Sentiment Review & Verified Short-Term Trading Plans - Улправда
Hedge Fund Moves: How strong is Azenta Inc. stock balance sheetJuly 2025 Highlights & Low Risk High Reward Ideas - Улправда
Form DEFR14A Azenta, Inc. - StreetInsider
Azenta (STU:BA3) EV-to-OCF : 16.73 (As of Dec. 19, 2025) - GuruFocus
Is Azenta Inc. stock a top pick in earnings seasonWeekly Stock Summary & Free Growth Oriented Trading Recommendations - Улправда
Azenta (NASDAQ:AZTA) Price Target Raised to $44.00 at Needham & Company LLC - MarketBeat
Azenta (AZTA): Needham Analyst Raises Price Target to $44 | AZTA Stock News - GuruFocus
Needham Raises Price Target on Azenta to $44 From $42, Keeps Buy Rating - marketscreener.com
Azenta, Inc. $AZTA Shares Sold by Squarepoint Ops LLC - MarketBeat
Will Azenta Inc. stock benefit from green energy trendsWeekly Profit Analysis & Verified Technical Signals - Bölüm Sonu Canavarı
How Azenta Inc. stock performs in rising dollar environmentSell Signal & Reliable Intraday Trade Alerts - Улправда
Azenta (NASDAQ: AZTA) outlines 2026 meeting, equity plan and governance - Stock Titan
Azenta, Inc. Announces Directors Not Nominated for Re-Election - marketscreener.com
How strong is Azenta Inc. stock balance sheetWeekly Trade Review & Accurate Buy Signal Notifications - Улправда
How Azenta Inc. stock benefits from tech adoptionTrade Exit Report & High Accuracy Swing Entry Alerts - Улправда
Azenta (AZTA) price target increased by 15.88% to 39.34 - MSN
Azenta, Inc. (NASDAQ:AZTA) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
What analysts say about Azenta Inc BA3 stockDividend Reinvestment Plans & Free High Return Strategy Alerts - earlytimes.in
New Strong Sell Stocks for Dec. 15 - Yahoo Finance
Azenta Life Sciences Storage System selected by UK Biocentre - MSN
Is Azenta’s US$250 Million Buyback And M&A Push Altering The Investment Case For AZTA? - simplywall.st
Stock Repurchase Program Declared by Azenta (NASDAQ:AZTA) - MarketBeat
Azenta outlines 3%–5% organic revenue growth and 300 bps margin expansion for 2026 amid operational overhaul - MSN
Natixis Takes Position in Azenta, Inc. $AZTA - MarketBeat
Azenta Authorizes $250 Million Share Repurchase Program - The Malaysian Reserve
Finanzdaten der Azenta Inc-Aktie (AZTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Azenta Inc-Aktie (AZTA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Lin Lawrence Y. | EVP, CFO and Treasurer |
Aug 11 '25 |
Buy |
27.96 |
2,500 |
69,900 |
46,013 |
| Hughes Violetta | VP, Chief Accounting Officer |
Feb 03 '25 |
Sale |
52.97 |
317 |
16,791 |
9,603 |
| Zhou Ginger | SVP and General Manager, Genom |
Jan 31 '25 |
Buy |
45.88 |
417 |
19,132 |
27,916 |
0.83%
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):